These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Post-marketing observational study of donepezil]. Ibach B Krankenpfl J; 2005; 43(1-3):25. PubMed ID: 15912820 [No Abstract] [Full Text] [Related]
6. Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study. Prasher VP; Adams C; Holder R; Int J Geriatr Psychiatry; 2003 Jun; 18(6):549-51. PubMed ID: 12789681 [No Abstract] [Full Text] [Related]
7. [Acetylcholinesterase inhibitor. Helpful not just in Alzheimer dementia]. MMW Fortschr Med; 2002 Aug; 144(33-34):59. PubMed ID: 12380156 [No Abstract] [Full Text] [Related]
8. Alcohol abuse in an elderly woman taking donepezil for Alzheimer disease. Marinho V; Laks J; Engelhardt E; Conn D J Clin Psychopharmacol; 2006 Dec; 26(6):683-5. PubMed ID: 17110839 [No Abstract] [Full Text] [Related]
9. Donepezil (Aricept) for Alzheimer's disease. Med Lett Drugs Ther; 1997 Jun; 39(1002):53-4. PubMed ID: 9187642 [No Abstract] [Full Text] [Related]
11. [[Donepezil : a new option in the treatment of Alzheimer's disease] ONEPA]. Azanza JR; Sádaba B; Quetglas EG; Escolar M Rev Med Univ Navarra; 1998; 42(2):109-18. PubMed ID: 10420948 [No Abstract] [Full Text] [Related]
12. AD2000: donepezil in Alzheimer's disease. Schneider LS Lancet; 2004 Jun; 363(9427):2100-1. PubMed ID: 15220027 [No Abstract] [Full Text] [Related]
13. Donepezil for Alzheimer's disease. Benjamin B; Burns A Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763 [TBL] [Abstract][Full Text] [Related]
14. Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease. Prescrire Int; 2003 Dec; 12(68):230-1. PubMed ID: 14986699 [TBL] [Abstract][Full Text] [Related]
15. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease. Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874 [No Abstract] [Full Text] [Related]
16. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study. Lu S; Hill J; Fillit H Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386 [TBL] [Abstract][Full Text] [Related]
17. The long-term efficacy and tolerability of donepezil in patients with vascular dementia. Wilkinson D; Róman G; Salloway S; Hecker J; Boundy K; Kumar D; Posner H; Schindler R Int J Geriatr Psychiatry; 2010 Mar; 25(3):305-13. PubMed ID: 19623601 [TBL] [Abstract][Full Text] [Related]
18. The use, benefits, and costs of cholinesterase inhibitors for Alzheimer's dementia in long-term care: are the data relevant and available? Khang P; Weintraub N; Espinoza RT J Am Med Dir Assoc; 2004; 5(4):249-55. PubMed ID: 15228635 [No Abstract] [Full Text] [Related]
19. Cholinesterase inhibitor treatment and urinary incontinence in Alzheimer's disease. Starr JM J Am Geriatr Soc; 2007 May; 55(5):800-1. PubMed ID: 17493206 [No Abstract] [Full Text] [Related]
20. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]